Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-10-02 4:01 pm Purchase | 13G | ELEVAI LABS INC ELAB | S.H.N. Financial Investments Ltd. | 3,041,575 9.99% | 3,041,575 (New Position) | View |
| 2024-10-01 4:01 pm Purchase | 13G | ELEVAI LABS INC ELAB | L1 Capital Global Opportunities Master Fund Ltd. | 3,171,061 9.99% | 3,171,061 (New Position) | View |
| 2024-09-26 6:28 pm Purchase | 13G | ELEVAI LABS INC ELAB | Altium Capital Management LP | 5,714,285 9.99% | 5,714,285 (New Position) | View |
| 2024-05-31 8:10 pm Purchase | 13G | ELEVAI LABS INC ELAB | MOA LIFE PLUS CO. LTD. | 950,000 5.03% | 950,000 (New Position) | View |
| 2024-02-21 10:57 am Purchase | 13D | ELEVAI LABS INC ELAB | Braeden Lichti | 3,823,965 22.07% | 3,823,965 (New Position) | View |
| 2024-02-14 09:30 am Purchase | 13G | ELEVAI LABS INC ELAB | Abou-Sayed Hatem | 1,517,738 8.7% | 1,517,738 (New Position) | View |
| 2024-02-14 09:30 am Purchase | 13G | ELEVAI LABS INC ELAB | Hatem Abou-Sayed MD MBA FACS a Professional Medical Corp | 1,371,905 7.9% | 1,371,905 (New Position) | View |
| 2024-02-14 09:30 am Purchase | 13G | ELEVAI LABS INC ELAB | Plews Jordan R. | 2,997,287 17% | 2,997,287 (New Position) | View |
| 2024-02-14 09:30 am Purchase | 13G | ELEVAI LABS INC ELAB | JP Bio Consulting LLC | 2,851,454 16.5% | 2,851,454 (New Position) | View |